John Lachin

Has grant

Professor

George Washington University

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

John Lachin is a Professor at George Washington University in the United States. His research focuses on diabetes, particularly Type 1 diabetes, and includes studies on the Diabetes Control and Complications Trial, neuropathic pain, and the role of C-Peptide in clinical trials. He has contributed significantly to understanding microvascular complications and the progression of diabetes through various epidemiological studies.

Recent Grants

Grant: Close

Glycemia Reduction Approaches in Diabetes: A comparative effectiveness study

Open Date: 2012-09-25

Close Date: 2017-07-31

Grant: Close

Epidemiology of Diabetes Interventions and Complications Data Coordinating Center

Open Date: 2012-08-15

Close Date: 2017-04-30

Grant: Close

Type 1 Diabetes Trialnet: Operations Coord. Center

Open Date: 2001-09-29

Close Date: 2010-06-30

Grant: Close

STATISTICAL METHODS FOR CHRONIC DISEASE CLINICAL TRIALS

Open Date: 1985-07-01

Close Date: 1990-06-30

Grant: Close

COMPLICATIONS OF INSULIN-DEPENDENT DIABETES MELLITUS

Open Date: 1982-02-08

Close Date: 1987-02-07

Articles (13)

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Collaborators (3)

Grecio Sandoval

Assistant Research Professor

The George Washington University Milken Institute of Public Health

UNITED STATES

View details

Bernard Zinman

University of Toronto

CANADA

View details

Colin Dayan

Professor of Clinical Diabetes and Metabolism

Cardiff University

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

John Lachin

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (13)

Evidence for C-Peptide as a Validated Surrogate to Predict Clinical Benefits in Trials of Disease-Modifying Therapies for Type 1 Diabetes

History of the Diabetes Control and Complications Trial and Its Follow-up Epidemiology of Diabetes Interventions and Complications Study: Studies That Changed the Treatment of Type 1 Diabetes

Neuropathic Pain With and Without Diabetic Peripheral Neuropathy in Type 1 Diabetes

Response to Comment on Lachin et al. Association of Estimated Time-in-Range Capillary Glucose Levels Versus HbA1c With Progression of Microvascular Complications in the Diabetes Control and Complications Trial. Diabetes Care 2022;45:2445–2448

Optimal Frequency of Urinary Albumin Screening in Type 1 Diabetes

Association of Estimated Time-in-Range Capillary Glucose Levels Versus HbA1c With Progression of Microvascular Complications in the Diabetes Control and Complications Trial

Physical Function in Middle-aged and Older Adults With Type 1 Diabetes: Long-term Follow-up of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study

Left Ventricular Structure, Tissue Composition, and Aortic Distensibility in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Intervention and Complications

Early Trajectory of Estimated Glomerular Filtration Rate and Long-term Advanced Kidney and Cardiovascular Complications in Type 1 Diabetes

Plasma advanced glycation end products and the subsequent risk of microvascular complications in type 1 diabetes in the DCCT/EDIC

The Beneficial Effects of Earlier Versus Later Implementation of Intensive Therapy in Type 1 Diabetes

Understanding Metabolic Memory: The Prolonged Influence of Glycemia During the Diabetes Control and Complications Trial (DCCT) on Future Risks of Complications During the Study of the Epidemiology of Diabetes Interventions and Complications (EDIC)

Cost‐efficient clinical studies with continuous time survival outcomes

Collaborators (3)

Grecio Sandoval

Bernard Zinman

Colin Dayan

Make your next move.